<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Merck Sharp &amp; Dohme Corp. v. Aurobindo Pharma, Ltd. et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2020cv01099/72974</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2020cv01099/72974/feed" rel="self" type="application/rss+xml" />
        <pubDate>Mon, 09 Nov 2026 05:32:31 -0800</pubDate>
        <lastBuildDate>Mon, 09 Nov 2026 05:32:31 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Merck Sharp &amp; Dohme Corp. v. Aurobindo Pharma, Ltd. et al - Docket Entries - Showing 1 through 22</description>
                                    <item>
        <title>
                            <![CDATA[Document 22]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Third Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629224</guid>
                <pubDate>
            Fri, 09 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 21]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629223</guid>
                <pubDate>
            Fri, 09 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 20]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629221</guid>
                <pubDate>
            Thu, 08 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (21 in 20-cv-949-RGA; 20 in 20-cv-1099-RGA; 246 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited, Aurobindo Pharma, Ltd., Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 10/8/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629222</guid>
                <pubDate>
            Thu, 08 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 19]]>
                    </title>
                <description>
            <![CDATA[
                Amended NOTICE of Deposition of Nurit Perlman by Merck Sharp & Dohme Corp. (Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629220</guid>
                <pubDate>
            Tue, 06 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 18]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 11-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629219</guid>
                <pubDate>
            Mon, 05 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 17]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1) produced their Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard, 2) produced the DMF for the Sitagliptin API used in its ANDA Product pursuant to Paragraph 3(c)(ii) of the Scheduling Order, and 3) disclosed to Plaintiff whether Aurobindo could produce reasonable quantities of unexpired samples of Aurobindos ANDA Products and API. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629218</guid>
                <pubDate>
            Mon, 05 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Alexander S. Zolan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629217</guid>
                <pubDate>
            Fri, 02 Oct 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 16]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #8 Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629216</guid>
                <pubDate>
            Wed, 30 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 15]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 10/20/20 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 9/29/20. Associated Cases: 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(cak) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629214</guid>
                <pubDate>
            Tue, 29 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Bruce R. Genderson for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 20-cv-1227-RGA; 20-cv-1099-RGA; 20-cv-776-RGA; 20-cv-815-RGA; 20-cv-749-RGA; 20-cv-847-RGA; 20-cv-949-RGA (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629215</guid>
                <pubDate>
            Tue, 29 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(cak) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629213</guid>
                <pubDate>
            Tue, 29 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1) Default Standard Paragraph 3 Initial Disclosures and 2) Rule 26 Initial Disclosures filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629212</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery; and (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629211</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 1/22/2021. Amended Pleadings due by 1/22/2021. Fact Discovery completed by 1/22/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629209</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications for Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo)(Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629206</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629208</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00749-RGA et al.(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629210</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (9 in 20-cv-1227-RGA; 11 in 20-cv-1099-RGA; 30 in 20-cv-776-RGA; 19 in 20-cv-815-RGA; 21 in 20-cv-749-RGA; 19 in 20-cv-847-RGA; 12 in 20-cv-949-RGA)MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Alexander S. Zolan, Elise Baumgarten, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:20-cv-00749-RGA et al.(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629207</guid>
                <pubDate>
            Mon, 28 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/28/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629205</guid>
                <pubDate>
            Fri, 25 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd.. (Belgam, Neal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629204</guid>
                <pubDate>
            Wed, 16 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint, and Additional Defenses and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd..(Ormerod, Eve) Modified on 9/16/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629203</guid>
                <pubDate>
            Wed, 16 Sep 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 28, 2020 - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd.. (Ormerod, Eve) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629201</guid>
                <pubDate>
            Thu, 27 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #7 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 28, 2020 (*Reset Answer Deadlines: Aurobindo Pharma USA Inc. answer due 9/28/2020; Aurobindo Pharma, Ltd. answer due 9/28/2020). Signed by Judge Richard G. Andrews on 8/27/2020. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629202</guid>
                <pubDate>
            Thu, 27 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629200</guid>
                <pubDate>
            Wed, 26 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                DECLARATION of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 8/26/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629199</guid>
                <pubDate>
            Tue, 25 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629197</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629196</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 7/10/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: No earlier than 1/10/2023. (mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629195</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629194</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed with Jury Demand against Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3145522.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629193</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                No Summons Issued. (mal) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_9629198</guid>
                <pubDate>
            Fri, 21 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
